CN113122508A - 一株鸡传染性支气管炎细胞适应毒及其应用 - Google Patents
一株鸡传染性支气管炎细胞适应毒及其应用 Download PDFInfo
- Publication number
- CN113122508A CN113122508A CN202110345719.9A CN202110345719A CN113122508A CN 113122508 A CN113122508 A CN 113122508A CN 202110345719 A CN202110345719 A CN 202110345719A CN 113122508 A CN113122508 A CN 113122508A
- Authority
- CN
- China
- Prior art keywords
- virus
- infectious bronchitis
- cell
- cells
- strain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000700605 Viruses Species 0.000 title claims abstract description 62
- 230000003044 adaptive effect Effects 0.000 title claims abstract description 24
- 208000015181 infectious disease Diseases 0.000 title claims abstract description 23
- 206010006451 bronchitis Diseases 0.000 title claims abstract description 20
- 230000002458 infectious effect Effects 0.000 title claims abstract description 20
- 241000711450 Infectious bronchitis virus Species 0.000 claims abstract description 27
- 101100269369 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) AGE1 gene Proteins 0.000 claims abstract description 27
- 241000287828 Gallus gallus Species 0.000 claims abstract description 18
- 229960005486 vaccine Drugs 0.000 claims abstract description 14
- 238000012258 culturing Methods 0.000 claims description 18
- 238000011081 inoculation Methods 0.000 claims description 12
- 241000271566 Aves Species 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 108010019160 Pancreatin Proteins 0.000 claims description 9
- 229940055695 pancreatin Drugs 0.000 claims description 9
- 239000000427 antigen Substances 0.000 claims description 7
- 102000036639 antigens Human genes 0.000 claims description 7
- 108091007433 antigens Proteins 0.000 claims description 7
- 239000001963 growth medium Substances 0.000 claims description 6
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 5
- 239000002609 medium Substances 0.000 claims description 5
- 238000004321 preservation Methods 0.000 claims description 3
- 235000015097 nutrients Nutrition 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 230000001502 supplementing effect Effects 0.000 claims description 2
- 230000005847 immunogenicity Effects 0.000 abstract description 11
- 238000004519 manufacturing process Methods 0.000 abstract description 10
- 210000003837 chick embryo Anatomy 0.000 abstract description 6
- 241001465754 Metazoa Species 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 69
- 235000013330 chicken meat Nutrition 0.000 description 14
- 239000000243 solution Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 101150010882 S gene Proteins 0.000 description 4
- 230000006978 adaptation Effects 0.000 description 4
- 210000001161 mammalian embryo Anatomy 0.000 description 4
- 230000012010 growth Effects 0.000 description 3
- 230000003053 immunization Effects 0.000 description 3
- 238000002649 immunization Methods 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 210000002257 embryonic structure Anatomy 0.000 description 2
- 231100000758 embryotoxin Toxicity 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000003306 harvesting Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000711573 Coronaviridae Species 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- 208000001705 Mouth breathing Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000001779 embryotoxic effect Effects 0.000 description 1
- 231100000238 embryotoxicity Toxicity 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 201000003102 mental depression Diseases 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- -1 therefore Proteins 0.000 description 1
- 230000005100 tissue tropism Effects 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 210000003501 vero cell Anatomy 0.000 description 1
- 239000005723 virus inoculator Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110345719.9A CN113122508A (zh) | 2021-03-30 | 2021-03-30 | 一株鸡传染性支气管炎细胞适应毒及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110345719.9A CN113122508A (zh) | 2021-03-30 | 2021-03-30 | 一株鸡传染性支气管炎细胞适应毒及其应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113122508A true CN113122508A (zh) | 2021-07-16 |
Family
ID=76774320
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110345719.9A Pending CN113122508A (zh) | 2021-03-30 | 2021-03-30 | 一株鸡传染性支气管炎细胞适应毒及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113122508A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110129281A (zh) * | 2019-05-15 | 2019-08-16 | 成都天邦生物制品有限公司 | 一种使用悬浮细胞培养新城疫病毒的方法及应用 |
CN113980912A (zh) * | 2021-10-26 | 2022-01-28 | 南京农业大学 | 可复制ibv病毒qx亚型毒株的基因敲除细胞系及其构建方法和应用 |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0212703A1 (en) * | 1985-07-18 | 1987-03-04 | Duphar International Research B.V | Infectious bronchitis vaccines for day-old chickens |
US20110269116A1 (en) * | 2008-03-04 | 2011-11-03 | Probiogen Ag | Cell Line From Rousettus As Host Cell For Pathogen Amplification |
CN102851257A (zh) * | 2012-08-27 | 2013-01-02 | 上海启盛生物科技有限公司 | 一种鸡传染性支气管炎病毒减毒疫苗株及其应用 |
WO2014061914A1 (ko) * | 2012-10-15 | 2014-04-24 | 건국대학교 산학협력단 | 전염성기관지염 바이러스 k40/09주 및 이를 이용한 전염성 기관지염 백신 |
US20160106828A1 (en) * | 2014-10-20 | 2016-04-21 | Auburn University | Adaptation of attenuated infectious bronchitis virus (ibv) to embryonic kidney cells and vaccine thereby produced |
CN107893057A (zh) * | 2017-12-27 | 2018-04-10 | 北京华都诗华生物制品有限公司 | 鸡传染性支气管炎病毒弱毒株及其构建方法和应用 |
CN108300704A (zh) * | 2018-02-08 | 2018-07-20 | 华农(肇庆)生物产业技术研究院有限公司 | 一种用传代细胞系悬浮培养传染性支气管炎病毒的方法 |
CN110129281A (zh) * | 2019-05-15 | 2019-08-16 | 成都天邦生物制品有限公司 | 一种使用悬浮细胞培养新城疫病毒的方法及应用 |
CN110404063A (zh) * | 2019-07-04 | 2019-11-05 | 商丘美兰生物工程有限公司 | 采用非免鸡蛋制备鸡传染性支气管炎病毒抗原的方法 |
CN111671892A (zh) * | 2020-05-07 | 2020-09-18 | 成都天邦生物制品有限公司 | 全悬浮鸭胚视网膜细胞在鸡产蛋下降综合症疫苗中的应用 |
CN112156182A (zh) * | 2020-11-10 | 2021-01-01 | 成都天邦生物制品有限公司 | 一种全悬浮细胞源鸡新城疫、禽流感二联灭活疫苗 |
CN112961837A (zh) * | 2021-03-01 | 2021-06-15 | 武汉科前生物股份有限公司 | 一种新城疫vii型弱毒株无血清全悬浮细胞培养的方法 |
-
2021
- 2021-03-30 CN CN202110345719.9A patent/CN113122508A/zh active Pending
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0212703A1 (en) * | 1985-07-18 | 1987-03-04 | Duphar International Research B.V | Infectious bronchitis vaccines for day-old chickens |
US20110269116A1 (en) * | 2008-03-04 | 2011-11-03 | Probiogen Ag | Cell Line From Rousettus As Host Cell For Pathogen Amplification |
CN102851257A (zh) * | 2012-08-27 | 2013-01-02 | 上海启盛生物科技有限公司 | 一种鸡传染性支气管炎病毒减毒疫苗株及其应用 |
WO2014061914A1 (ko) * | 2012-10-15 | 2014-04-24 | 건국대학교 산학협력단 | 전염성기관지염 바이러스 k40/09주 및 이를 이용한 전염성 기관지염 백신 |
US20160106828A1 (en) * | 2014-10-20 | 2016-04-21 | Auburn University | Adaptation of attenuated infectious bronchitis virus (ibv) to embryonic kidney cells and vaccine thereby produced |
CN107893057A (zh) * | 2017-12-27 | 2018-04-10 | 北京华都诗华生物制品有限公司 | 鸡传染性支气管炎病毒弱毒株及其构建方法和应用 |
CN108300704A (zh) * | 2018-02-08 | 2018-07-20 | 华农(肇庆)生物产业技术研究院有限公司 | 一种用传代细胞系悬浮培养传染性支气管炎病毒的方法 |
CN110129281A (zh) * | 2019-05-15 | 2019-08-16 | 成都天邦生物制品有限公司 | 一种使用悬浮细胞培养新城疫病毒的方法及应用 |
CN110404063A (zh) * | 2019-07-04 | 2019-11-05 | 商丘美兰生物工程有限公司 | 采用非免鸡蛋制备鸡传染性支气管炎病毒抗原的方法 |
CN111671892A (zh) * | 2020-05-07 | 2020-09-18 | 成都天邦生物制品有限公司 | 全悬浮鸭胚视网膜细胞在鸡产蛋下降综合症疫苗中的应用 |
CN112156182A (zh) * | 2020-11-10 | 2021-01-01 | 成都天邦生物制品有限公司 | 一种全悬浮细胞源鸡新城疫、禽流感二联灭活疫苗 |
CN112961837A (zh) * | 2021-03-01 | 2021-06-15 | 武汉科前生物股份有限公司 | 一种新城疫vii型弱毒株无血清全悬浮细胞培养的方法 |
Non-Patent Citations (7)
Title |
---|
YEFEI ZHOU等: "Immune response of AA broilers to IBV H120 vaccine and sodium new houttuyfonate", 《RESEARCH IN VETEINARY SCIENCE》 * |
张玉杨等: "鸡传染性支气管炎H120鸡胚毒与细胞毒的免疫效力比较试验", 《河南农业科学》 * |
张玉杨等: "鸡传染性支气管炎病毒H_(120)株细胞适应毒的培育研究", 《华北农学报》 * |
易中等: "新疆鸡传染性法氏囊病病毒生物学特性的研究", 《中国预防兽医学报》 * |
李树根等: "鸡马立克氏病Ⅰ型弱毒株的选育", 《中国兽医杂志》 * |
李自良等: "MDCK悬浮细胞制备及流感病毒敏感性研究", 《中国人兽共患病学报》 * |
程旭等: "Vero细胞悬浮驯化及增殖鸡传染性支气管炎病毒工艺研究", 《现代畜牧兽医》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110129281A (zh) * | 2019-05-15 | 2019-08-16 | 成都天邦生物制品有限公司 | 一种使用悬浮细胞培养新城疫病毒的方法及应用 |
CN113980912A (zh) * | 2021-10-26 | 2022-01-28 | 南京农业大学 | 可复制ibv病毒qx亚型毒株的基因敲除细胞系及其构建方法和应用 |
CN113980912B (zh) * | 2021-10-26 | 2024-03-26 | 南京农业大学 | 可复制ibv病毒qx亚型毒株的基因敲除细胞系及其构建方法和应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111632137B (zh) | 猫杯状病毒病、猫传染性鼻气管炎和猫泛白细胞减少症三联疫苗及其制备方法和应用 | |
JP5264843B2 (ja) | 細胞培養におけるインフルエンザウイルスの複製の方法、および本方法によって入手可能なインフルエンザウイルス | |
CN102250843B (zh) | 猪繁殖与呼吸综合征病毒基因工程标记弱毒疫苗株及应用 | |
CN113122508A (zh) | 一株鸡传染性支气管炎细胞适应毒及其应用 | |
CN108300704B (zh) | 一种用传代细胞系悬浮培养传染性支气管炎病毒的方法 | |
CN110237246B (zh) | 一种全悬浮细胞培养禽流感(h9)灭活疫苗的方法 | |
CN111041002B (zh) | 猪流行性腹泻病毒变异株2a、2b二价灭活疫苗及其制备方法 | |
WO2023246621A1 (zh) | 柯萨奇病毒a10型毒株及其应用 | |
CN114854697B (zh) | 一种猪轮状病毒g4-g5-g9型三价灭活疫苗及其制备方法和用途 | |
CN114107170A (zh) | 猫肾悬浮细胞系及其构建方法与应用 | |
CN113388587A (zh) | 表达牛病毒性腹泻e2基因的重组牛结节疹病毒及其应用 | |
CN114276981B (zh) | 一种适应猪流行性腹泻病毒的Vero-E6悬浮细胞株sVero-E6及其应用 | |
CN104894054B (zh) | 一种猴胚胎肾上皮细胞Marc‑145悬浮适应株及其在培养蓝耳病病毒、生产蓝耳病毒疫苗中的应用 | |
CN114525261A (zh) | 一种猪流行性腹泻、猪轮状病毒二联灭活疫苗及其制备方法 | |
CN106237323B (zh) | 猪蓝耳病纯化疫苗及其制备方法 | |
WO1998035023A1 (en) | Method for growing porcine reproductive and respiratory syndrome virus for use as vaccines and diagnostic assays | |
CN110124025A (zh) | 一种禽流感与禽腺病毒4型二联基因工程亚单位疫苗及其制备方法 | |
CN111671892A (zh) | 全悬浮鸭胚视网膜细胞在鸡产蛋下降综合症疫苗中的应用 | |
CN109776657A (zh) | 重组诺如病毒vlp颗粒和制备方法及其用途 | |
CN116218763A (zh) | 一种猪流行性腹泻病毒株的全悬浮细胞培养方法 | |
CN106237324B (zh) | 一种使用全悬浮技术生产猪传染性胃肠炎疫苗的方法 | |
CN113322241B (zh) | 一种牛副流感病毒3型病毒株bpiv3-nm及其应用 | |
CN114591920A (zh) | 猪流行性腹泻病毒毒株、灭活疫苗及其应用 | |
CN111961652A (zh) | 一种禽偏肺病毒的无血清全悬浮培养方法及其在疫苗中的应用 | |
CN110819599B (zh) | 一种预防台湾型传染性支气管炎的疫苗株 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: No.358, lingchi street, Chengdu Economic and Technological Development Zone, Sichuan 610000 Applicant after: Chengdu Shiji biopharmaceutical Co.,Ltd. Applicant after: Shiji Biotechnology (Nanjing) Co.,Ltd. Address before: No.358, lingchi street, Chengdu Economic and Technological Development Zone, Sichuan 610000 Applicant before: CHENGDU TECBOND BIOLOGICAL PRODUCTS CO.,LTD. Applicant before: Shiji Biotechnology (Nanjing) Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20221201 Address after: No.358, lingchi street, Chengdu Economic and Technological Development Zone, Sichuan 610000 Applicant after: Chengdu Shiji biopharmaceutical Co.,Ltd. Address before: No.358, lingchi street, Chengdu Economic and Technological Development Zone, Sichuan 610000 Applicant before: Chengdu Shiji biopharmaceutical Co.,Ltd. Applicant before: Shiji Biotechnology (Nanjing) Co.,Ltd. |
|
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210716 |